Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes.
Journal Information
Full Title: Diabetes Care
Abbreviation: Diabetes Care
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Duality of Interest. M.J.H. is a member of the scientific advisory board for SAb Biotherapeutics, a company developing a humanized version of ATG and seeking to eliminate SS, and has been a consultant for Sanofi. M.A.A. holds a patent for combination therapies with ATG. No other potential conflicts of interest relevant to this article were reported."
"This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (P01 AI042288)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025